Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunomodulating CB2 receptor ligands in development at Sanofi-Synthelabo

Feb. 7, 2000

Cel-Sci receives MIPS award to support TB vaccine development

Feb. 2, 2000

Nexell acquires access to Diaclone antibodies for use in cell therapy

Feb. 2, 2000

Application of Ariad's Dimerizer Drug technology covered by two U.S. patents

Jan. 31, 2000

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

Jan. 28, 2000

PADRE technology shows promise as universal vaccine immune stimulant

Jan. 26, 2000

North American Vaccine submits NeisVac-C for U.K. approval

Jan. 25, 2000

Peptide Therapeutics' C. difficile vaccine: positive phase I/II results

Jan. 25, 2000

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Jan. 24, 2000

SmithKline Beecham signs CpG DNA immune stimulant agreement

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.